Routine screening for chronic human immunodeficiency virus infection: Why don't the guidelines agree?

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Infection with human immunodeficiency virus remains a major public health problem in the United States. Prominent guidelines from the U.S. Preventive Services Task Force and the Centers for Disease Control and Prevention differ in their recommendations on whether and how to screen adults and adolescents not known to be at higher risk. These discrepancies have led to controversy and debate as well as confusion among clinicians. This article reviews principles of screening, explains specific issues related to screening for human immunodeficiency virus, reviews the discrepancies between the US Preventive Services Task Force and the Centers for Disease Control and Prevention guidelines and the methods used in each guideline, and describes potential reasons for the discrepancies. The case of screening for human immunodeficiency virus illustrates how discrepancies between guidelines may be related to different guideline development methods as well as the different perspectives of the guideline development groups.

Original languageEnglish (US)
Pages (from-to)7-19
Number of pages13
JournalEpidemiologic Reviews
Volume33
Issue number1
DOIs
StatePublished - Jul 2011

Fingerprint

Virus Diseases
HIV
Guidelines
Advisory Committees
Centers for Disease Control and Prevention (U.S.)
Public Health
Infection

Keywords

  • guidelines as topic
  • health planning guidelines
  • HIV
  • mass screening

ASJC Scopus subject areas

  • Epidemiology

Cite this

Routine screening for chronic human immunodeficiency virus infection : Why don't the guidelines agree? / Chou, Roger.

In: Epidemiologic Reviews, Vol. 33, No. 1, 07.2011, p. 7-19.

Research output: Contribution to journalArticle

@article{3c767dd0ec274de08634ffef19afca0c,
title = "Routine screening for chronic human immunodeficiency virus infection: Why don't the guidelines agree?",
abstract = "Infection with human immunodeficiency virus remains a major public health problem in the United States. Prominent guidelines from the U.S. Preventive Services Task Force and the Centers for Disease Control and Prevention differ in their recommendations on whether and how to screen adults and adolescents not known to be at higher risk. These discrepancies have led to controversy and debate as well as confusion among clinicians. This article reviews principles of screening, explains specific issues related to screening for human immunodeficiency virus, reviews the discrepancies between the US Preventive Services Task Force and the Centers for Disease Control and Prevention guidelines and the methods used in each guideline, and describes potential reasons for the discrepancies. The case of screening for human immunodeficiency virus illustrates how discrepancies between guidelines may be related to different guideline development methods as well as the different perspectives of the guideline development groups.",
keywords = "guidelines as topic, health planning guidelines, HIV, mass screening",
author = "Roger Chou",
year = "2011",
month = "7",
doi = "10.1093/epirev/mxr001",
language = "English (US)",
volume = "33",
pages = "7--19",
journal = "Epidemiologic Reviews",
issn = "0193-936X",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Routine screening for chronic human immunodeficiency virus infection

T2 - Why don't the guidelines agree?

AU - Chou, Roger

PY - 2011/7

Y1 - 2011/7

N2 - Infection with human immunodeficiency virus remains a major public health problem in the United States. Prominent guidelines from the U.S. Preventive Services Task Force and the Centers for Disease Control and Prevention differ in their recommendations on whether and how to screen adults and adolescents not known to be at higher risk. These discrepancies have led to controversy and debate as well as confusion among clinicians. This article reviews principles of screening, explains specific issues related to screening for human immunodeficiency virus, reviews the discrepancies between the US Preventive Services Task Force and the Centers for Disease Control and Prevention guidelines and the methods used in each guideline, and describes potential reasons for the discrepancies. The case of screening for human immunodeficiency virus illustrates how discrepancies between guidelines may be related to different guideline development methods as well as the different perspectives of the guideline development groups.

AB - Infection with human immunodeficiency virus remains a major public health problem in the United States. Prominent guidelines from the U.S. Preventive Services Task Force and the Centers for Disease Control and Prevention differ in their recommendations on whether and how to screen adults and adolescents not known to be at higher risk. These discrepancies have led to controversy and debate as well as confusion among clinicians. This article reviews principles of screening, explains specific issues related to screening for human immunodeficiency virus, reviews the discrepancies between the US Preventive Services Task Force and the Centers for Disease Control and Prevention guidelines and the methods used in each guideline, and describes potential reasons for the discrepancies. The case of screening for human immunodeficiency virus illustrates how discrepancies between guidelines may be related to different guideline development methods as well as the different perspectives of the guideline development groups.

KW - guidelines as topic

KW - health planning guidelines

KW - HIV

KW - mass screening

UR - http://www.scopus.com/inward/record.url?scp=79960503995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960503995&partnerID=8YFLogxK

U2 - 10.1093/epirev/mxr001

DO - 10.1093/epirev/mxr001

M3 - Article

C2 - 21597095

AN - SCOPUS:79960503995

VL - 33

SP - 7

EP - 19

JO - Epidemiologic Reviews

JF - Epidemiologic Reviews

SN - 0193-936X

IS - 1

ER -